| abstract |
The present invention provides a radiopharmaceutical composition comprising the following four components: (i) a radiolabeled compound; (ii) ethanol; (iii) a stabilizer for the radiolabeled compound; and (iv) a cyclodextrin. The present invention also provides a radiopharmaceutical composition, comprising: (i) a radiolabeled compound; (ii) a stabilizer for the radiolabeled compound, wherein the stabilizer comprises: ascorbic acid, aspartic acid, cysteine, Maleic acid, gentisic acid, glutathione, glutamic acid, mannitol, niacinamide, calcium chloride, N-tert-butyl-α-phenylnitrone (PBN), tartaric acid, p-aminobenzoic acid ( pABA), chloride ions or salts, or combinations thereof; and (iii) cyclodextrins. |